
News|Articles|March 17, 2026
Challenging Cases®: Firsthand insight into oncology decision‑making
Author(s)IntrinsiQ Specialty Solutions
Through interactive, quantitative live and virtual double-blinded case-based sessions followed by a national key opinion leader data-focused discussion, Challenging Cases offers a window into how oncologists select treatment options, balance clinical considerations, and respond to complex patient scenarios, providing insight into the factors shaping real-world treatment decisions.
Trending on PharmExec
1
Reshoring Pharma and Biotech Manufacturing Ahead of This Summer’s Tariff Deadlines: Q&A with Ryan Last
2
How Regulatory Stringency, Demand Shocks, and Repurposing Reshape Biopharma Strategy in 2026
3
Traditional Healthcare Has a Retention Problem It Refuses to Diagnose
4
Novartis to Acquire Myricx Bio for $1.1 Billion
5